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Abstract
Background: Bovine tuberculosis is an enduring disease of cattle that has significant repercussions
for human health. The advent of high-throughput functional genomics technologies has facilitated
large-scale analyses of the immune response to this disease that may ultimately lead to novel
diagnostics and therapeutic targets. Analysis of mRNA abundance in peripheral blood mononuclear
cells (PBMC) from six Mycobacterium bovis infected cattle and six non-infected controls was
performed. A targeted immunospecific bovine cDNA microarray with duplicated spot features
representing 1,391 genes was used to test the hypothesis that a distinct gene expression profile
may exist in M. bovis infected animals in vivo.
Results: In total, 378 gene features were differentially expressed at the P ≤ 0.05 level in bovine
tuberculosis (BTB)-infected and control animals, of which 244 were expressed at lower levels
(65%) in the infected group. Lower relative expression of key innate immune genes, including the
Toll-like receptor 2 (TLR2) and TLR4 genes, lack of differential expression of indicator adaptive
immune gene transcripts (IFNG, IL2, IL4), and lower BOLA major histocompatibility complex – class
I (BOLA) and class II (BOLA-DRA) gene expression was consistent with innate immune gene
repression in the BTB-infected animals. Supervised hierarchical cluster analysis and class prediction
validation identified a panel of 15 genes predictive of disease status and selected gene transcripts
were validated (n = 8 per group) by real time quantitative reverse transcription PCR.
Conclusion: These results suggest that large-scale expression profiling can identify gene signatures
of disease in peripheral blood that can be used to classify animals on the basis of in vivo infection, in
the absence of exogenous antigenic stimulation.
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Background
Mycobacterium bovis infection is the cause of bovine tuber-
culosis, an important health problem in cattle with
zoonotic potential for transmission to humans. In cattle
this infection can be slowly progressive, with limited out-
ward signs of disease, making diagnosis and eradication
of tuberculosis difficult. Current diagnostic techniques
often involve an in vivo single intradermal comparative
tuberculin test (SICTT), alone, or combined with an in
vitro ELISA based interferon-γ assay (IFN-γ) [1,2]. How-
ever, problems remain with the sensitivity of current diag-
nostics leading to a failure to detect all infected animals
[3,4].
Following initial exposure to M. bovis, a specific T-cell
immune response develops characterized by the release of
proinflammatory cytokines including IFN-γ [5,6]. The loss
of this early proinflammatory cytotoxic response is
thought to be associated with an inability to control infec-
tion, resulting in progression to clinical disease [6,7]. The
persistence of infection leading to chronic tuberculosis
may be due to an ineffective immune response that
involves suppression of specific immune mechanisms [6].
The immune response to tuberculosis is a complex proc-
ess and studies in the bovine model have primarily
focused on the adaptive immune response. Although the
T-cell response is critical in controlling tuberculosis infec-
tion in cattle [6], studies in mice and humans suggest a
significant role for innate immune mechanisms in
mounting early and effective immune responses to myco-
bacterial infection [8-10]. Development of an effective
adaptive immune response is dependent on innate
immune activation. The innate immune response is regu-
lated via receptors for antigen recognition known as path-
ogen recognition receptors (PRRs) and antigen
presentation molecules. PRRs including the Toll-like
receptors (TLRs) have been implicated in the immune
response to M. bovis BCG [11,12], specifically TLR-2 and
TLR-4 [9]. A diverse range of mechanisms used by myco-
bacteria to subvert the host immune response have also
been described [13,14]. Mycobacteria can inhibit host cell
signalling via the TLRs and other mediators of the innate
immune response [15]; they may also interfere with mat-
uration of the phagosome in infected macrophages,
thereby reducing the ability of the host to successfully
eliminate the pathogen [16,15]. Failure or subversion of
an appropriate innate immune response may therefore be
critical to the establishment of infection and progression
to disease [6].
In recent years, high-throughput genomic analyses have
facilitated identification of transcriptional regulatory net-
works involved in the orchestration of the immune
response [17,18]. Gene expression studies of host
responses to infection can provide a powerful tool for
understanding the interactions between pathogens and
the host immune system and may be particularly power-
ful in identifying specific molecules or pathways that have
been targeted by pathogens for immune evasion [19].
One desirable outcome of genomic analyses across large
gene subsets is the identification of an infection expres-
sion signature that may be used to differentiate groups
based on their infection status [20]. Microarrays have
recently been applied to the study of M. tuberculosis infec-
tion [18] and unique host gene expression signatures have
been attributed to specific strains of M. avium in human
macrophages [21]. In cattle, microarray studies of periph-
eral blood mononuclear cells (PBMC) from M. avium
subsp. paratuberculosis (MAP)-infected cattle have revealed
MAP-associated gene profiles, which include cytokines
and other putative biomarkers that are indicative of infec-
tion status [22,23]. These investigations also revealed that
differential gene expression patterns were identifiable irre-
spective of whether PBMC were stimulated with antigen.
Differential gene expression patterns may therefore pro-
vide useful novel diagnostic and prognostic tools [20,24].
We have previously used a bovine targeted immunospe-
cific cDNA microarray to study gene expression changes in
PBMC from bovine tuberculosis-(BTB-) infected cattle
cultured in vitro in the presence of bovine and avian tuber-
culins [25]. Stimulation with tuberculin antigens induced
significant expression changes in a range of immune
genes. In addition, the pattern of expression of many
other genes provided evidence of an M. bovis-specific sig-
nature of infection. In the present study, we have used an
expanded microarray platform to investigate gene expres-
sion differences that exist between infected and healthy
control cattle in vivo, in the absence of in vitro antigenic
stimulation. The results have yielded insights regarding
the immune response to bovine tuberculosis, indicating
that the expression of innate immune genes in in vivo
infected animals is suppressed. This innate immune gene
repression may limit the initiation of an appropriate
adaptive immune response, which may contribute to pro-
gression of the disease. This study has demonstrated the
involvement of a number of genes previously not associ-
ated with host defence or inflammation and has used
stringent microarray analysis methods to detect and vali-
date a robust gene signature of infection. The results high-
light the usefulness of large-scale genomics approaches to
detect biomarkers of disease and gene signatures of infec-
tion that in future may form the basis for novel diagnos-
tics and/or therapeutics.BMC Genomics 2007, 8:400 http://www.biomedcentral.com/1471-2164/8/400
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Results
Analysis of leukocyte cell population subsets and IFN-γ 
release from control and BTB-infected animals
The infected animals used in this study were chosen on
the basis of their large responses to the comparative tuber-
culin skin test. The IFN-γ levels measured in whole blood
of the infected animals were at least 25-fold greater than
in the healthy control cattle (P < 0.001, data not shown),
demonstrating that the infected animals were generating
strong cell mediated immune responses. At post-mortem,
each of the infected animals displayed gross tuberculosis
lesions and were classified as being in the advanced stage
of clinical disease. To rule out gene expression changes
that might be attributable to differences in leukocyte pop-
ulations between infected and control animals, whole
blood samples were subjected to haematological analysis.
There was no statistically significant difference in total
white blood cell (WBC) counts between control and BTB-
infected cattle (P = 0.721). However, neutrophil counts
were significantly decreased and lymphocytes were signif-
icantly increased in BTB-infected cattle (P = 0.002 and P <
0.001 respectively, Fig. 1). Lymphocytes represented
72.4% of cells present in the total WBC samples from the
BTB-infected group, but only 43.9% of WBC from the
control group. A small reduction in the proportion of
monocytes from 7% in the control animal samples to 4%
in the BTB-infected animal samples was also observed.
Microarray gene expression profile in BTB-infected cattle
Microarray analysis of mRNA was compared in the PBMC
of six M. bovis infected cattle and six non-infected controls
to investigate differential gene expression. The expression
data generated from the microarray experiment were
deposited in the NCBI Gene Expression Omnibus (GEO)
repository [26] with experiment series accession
GSE8857.
Of the 1,391 duplicated genes on the BOTL-5 microarray,
378 spot features showed significant differential expres-
sion between the BTB-infected and non-infected control
animals at the P ≤ 0.05 level (see Additional file 1). Of
these, 151 were significant at P ≤ 0.01 (Fig. 2) [see Addi-
tional file 1]. Among the 378 differentially expressed spot
features, 134 were significantly increased in expression in
BTB-infected animals (P ≤ 0.05), and 244 spot features
were significantly reduced in expression in BTB-infected
animals (P ≤ 0.05) compared to control animal samples.
This trend was replicated at the P ≤ 0.01 level (Fig. 2).
Analysis of leukocyte cell population subset Figure 1
Analysis of leukocyte cell population subset. Analysis of leukocyte cell population subsets were performed on whole 
blood sampled in vivo for BTB-infected (A) and healthy control cattle (B). The lymphocyte and monocyte subpopulations are 
retained in peripheral blood mononuclear cells (PBMC).BMC Genomics 2007, 8:400 http://www.biomedcentral.com/1471-2164/8/400
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261 of the spot features represent 122 genes, where at least
two replicate gene spot features were found to be signifi-
cantly differentially expressed; 21 of these genes were
identified as BOTL clones with no current gene match (see
Additional file 2).
Furthermore, 90 of the 122 genes were expressed at lower
levels in BTB-infected animals compared with non-
infected controls. Among the genes reduced in expression
with immune-related functions were PRKCB1,  PRKCA,
AKT1, AKT2, EEF2, EEF1G, GATA4 and IER5. Other genes
normally associated with a proinflammatory immune
response including CSF2 (-3.67 fold), CD14 (-3.08 fold),
CCL1  (-4.86 fold), CHUK  (-1.85 fold), NFKB1  (-2.89
fold), TBK1 (-1.63 fold), MIF (-1.91 fold), CCR7 (-2.49
fold), BOLA (-4.32 fold) and BOLA-DRA (-1.69) genes all
displayed lower expression levels in BTB-infected animals
relative to the control animal group (P ≤ 0.05).
Messenger RNA (mRNA) transcripts for only 32 of the 122
genes showed higher levels of expression in BTB-infected
animals. Most of these genes were EST sequences, the
functions of which remain to be elucidated. Genes with
increased expression and well characterised functions
include the platelet-derived growth factor family, repre-
sented by the PDGFA and PDGFB genes (1.70 and 1.61
fold, respectively) and ECGF1 (1.77 fold). Also signifi-
cantly increased were G protein-coupled receptor family 1
members MCHR1 (1.84 fold) and GPR98 (2.07 fold), a
member of the receptor tyrosine kinase subfamily AXL
(1.59 fold), a member of the Ig superfamily CD84 (1.53
fold) and the cytokine, CCL15  (1.60 fold) [and repre-
sented by replicate significant gene features at P ≤ 0.05].
Fold change differences for differentially expressed genes
on the microarray ranged from a decrease of 5.13 fold (the
major histocompatibility complex, class I, A gene [BOLA]
to an increase in expression of 2.14 fold (the growth arrest
and DNA-damage-inducible, alpha gene [GADD45A]) in
the BTB-infected cattle relative to control animals.
Analysis of the microarray experimental false discovery 
rate (type 1 error)
Investigation of the experiment-specific false discovery
rate (FDR) using exact multivariate permutations tests
based on 462 available permutations demonstrated that
the probability of obtaining at least 151 genes significant
by chance (at the P ≤ 0.01 level) if there are no real differ-
ences between the classes is 0.011. Furthermore, permuta-
tion-based analysis of the data using the Significance
Analysis of Microarrays (SAM) package with 403 differen-
tially expressed spot features (comparable to the 378 spot
features obtained using conventional statistical analyses),
demonstrated that only 15 of these 403 spot features were
false positives (data not shown).
Real time quantitative PCR (qRT-PCR) supports a trend of 
innate immune gene repression in BTB-infected cattle
An extended panel of 16 animals was used for real time
qRT-PCR validation studies (BTB-infected cattle [n = 8]
and control cattle [n = 8]). The 122 genes represented by
significant replicate spot features were classified using
gene ontology (GO). Selected genes from each GO class,
supplemented with genes selected from relevant literature
in human and murine models of TB were then used for
these single gene expression studies are detailed in Table
1 (and shown in Fig. 3). Real time qRT-PCR data obtained
for the following 17 genes; EEF1G, CXCR3, IER5, PHB2,
STK17B,  CD84,  MCL1,  CCL1,  TBK1,  AKT1,  PRKCB1,
NFKB1, RPS6KB2, BCL2, TNF, CD81, and NFATC4 cor-
roborated the BOTL-5 microarray results obtained using
RNA from the BTB-infected and control animals' PBMC
(see Table 1 and Fig. 3). The most notable difference in
gene expression was observed for the NFATC4 gene where
its expression was increased by more than 13-fold in
PBMC samples from BTB-infected cattle.
Expression levels of a number of genes involved in patho-
gen recognition, such as TLR2  and  TLR4, as well as
cytokine genes were also investigated by real time qRT-
PCR (Fig. 3). The TLR2 and TLR4 genes were expressed at
lower levels in BTB-infected animals compared with con-
trols by -2.37 (P = 0.011) and -1.22 fold (P  = 0.012)
respectively. ADAM17 expression levels were also signifi-
Differentially expressed genes between BTB-infected and  control cattle Figure 2
Differentially expressed genes between BTB-infected 
and control cattle. Statistically significant differentially 
expressed gene spot features between PBMC samples from 
BTB-infected (n = 6) and uninfected control animals (n = 6) in 
vivo at two different alpha levels (P ≤ 0.05 and P ≤ 0.01). For 
each P value, the number of genes with increased or 
decreased expression is shown for the BTB-infected animals 
relative to the control animals (see Additional files 1 and 2).BMC Genomics 2007, 8:400 http://www.biomedcentral.com/1471-2164/8/400
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Genes chosen for real time qRT-PCR data validation Figure 3
Genes chosen for real time qRT-PCR data validation. Shown are relative levels of differential gene expression con-
firmed between treatment groups ex vivo using real time qRT-PCR. Fold change values are shown for PBMC from BTB-infected 
cattle (n = 8) relative to PBMC from healthy control animals (n = 8). Error bars show the standard error of the mean for each 
gene.BMC Genomics 2007, 8:400 http://www.biomedcentral.com/1471-2164/8/400
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Table 1: Gene expression fold-change differences between BTB-infected animals (n = 8) and control animals (n = 8) using real time 
qRT-PCR
Gene symbol Gene name Gene ontology (GO) function/s Infected vs control group: 
relative expression
P-value
EEF1G Eukaryotic translation elongation 
factor 1 gamma gene
Protein binding, translation 
elongation factor activity
1.46 ± 0.07 < 0.0001
ADAM17 ADAM metallopeptidase domain 17 
(tumor necrosis factor, alpha, 
converting enzyme) gene
Metal ion binding, 
metalloendopeptidase activity, 
protein binding, zinc ion binding
-2.24 ± 0.28 < 0.0001
CXCR3 Chemokine (C-X-C motif) receptor 
3 gene
C-X-C chemokine receptor activity, 
receptor activity, rhodopsin-like 
receptor activity
-2.22 ± 0.18 < 0.0001
IER5 Immediate early response 5 gene Molecular function unknown -2.28 ± 0.26 < 0.0001
PHB2 Prohibitin 2 gene Estrogen receptor binding, protein 
binding, receptor activity, specific 
transcriptional repressor activity
-1.97 ± 0.19 < 0.0001
STK17B Serine/threonine kinase 17b 
(apoptosis-inducing) gene
ATP binding, nucleotide binding, 
protein serine/threonine kinase 
activity, transferase activity
-1.39 ± 0.11 0.0007
CD84 CD84 antigen gene Molecular function unknown 1.77 ± 0.48 0.0009
MCL1 Myeloid cell leukemia sequence 1 
(BCL2-related) gene
Protein binding, protein channel 
activity, protein heterodimerization 
activity
-1.07 ± 0.31 0.0013
CCL1 Chemokine (C-C motif) ligand 1 
gene
Chemokine activity -1.33 ± 0.09 0.0014
TBK1 TANK-binding kinase 1 gene ATP binding, nucleotide binding, 
protein serine/threonine kinase 
activity, signal transducer activity, 
transferase activity
-1.56 ± 0.19 0.0037
AKT1 V-akt murine thymoma viral 
oncogene homolog 1 gene
ATP binding, nucleotide binding, 
protein kinase activity, serine/
threonine kinase activity, transferase 
activity
-1.49 ± 0.16 0.0042
IL8 Interleukin 8 gene Chemokine activity, interleukin-8 
receptor binding, protein binding
-1.64 ± 0.64 0.0048
TLR2 Toll-like receptor 2 gene Gram-positive bacterial binding, 
lipopolysaccharide receptor activity, 
peptidoglycan binding, transferase 
activity
-2.37 ± 0.89 0.0108
PRKCB1 Protein kinase C, beta 1 gene ATP binding, calcium ion binding, 
diacylglycerol binding, protein kinase 
C activity, transferase activity, zinc 
ion binding
-1.13 ± 0.35 0.0111
TLR4 Toll-like receptor 4 Lipopolysaccharide binding, protein 
binding, transferase activity, 
transmembrane receptor activity
-1.22 ± 0.55 0.0116
NFKB1 Nuclear factor of kappa light 
polypeptide gene enhancer in B-cells 
1 (p105) gene
Protein binding, transcription factor 
activity
-1.02 ± 0.50 0.0228
IL16 Interleukin 16 (lymphocyte 
chemoattractant factor) gene
Cytokine activity, protein binding 1.33 ± 0.17 0.0326
RPS6KB2 Ribosomal protein S6 kinase, 70 kDa, 
polypeptide 2 gene
ATP binding, nucleotide binding, 
protein kinase activity, protein 
serine/threonine kinase activity, 
transferase activity
-0.92 ± 0.29 0.0342
BCL2 B-cell CLL/lymphoma 2 gene Identical protein binding -1.62 ± 0.61 0.0395
TNF Tumor necrosis factor (TNF 
superfamily, member 2) gene
Protein binding, tumor necrosis 
factor receptor binding
0.89 ± 0.46 0.0426
CD81 CD81 molecule gene Protein binding -1.23 ± 0.41 0.0477
NFATC4 Nuclear factor of activated T-cells, 
cytoplasmic, calcineurin-dependent 4 
gene
Transcription coactivator activity, 
transcription factor activity
13.22 ± 6.42 0.0482
Relative expression fold change values are shown with standard errors. Also shown are P-values from t-tests between the two groups.BMC Genomics 2007, 8:400 http://www.biomedcentral.com/1471-2164/8/400
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cantly lower (-2.24 fold, P = 0.001) in the BTB-infected
animals. Gene expression levels for the IL2, IL4 and IFNG
gene were not significantly different between BTB-infected
and control cattle groups (P > 0.05), consistent with the
microarray results. The interleukin 8 gene (IL8) was
expressed at a significantly lower level in BTB-infected ani-
mal samples (-1.64 fold, P = 0.005). In contrast, the IL16
gene was significantly increased in BTB-infected animals
(1.33 fold, P = 0.005) [see Table 1 and Fig. 3].
Cluster analysis identifies a gene expression signature of 
BTB infection
A hierarchical cluster dendrogram was constructed for the
12 animals screened with the BOTL-5 microarrays using
the expression data from a panel of the 15 most signifi-
cant differentially expressed genes (P ≤ 0.001). The results
of this hierarchical clustering are presented in Fig. 4 and
further details for the 15 genes used are provided in Table
2. This analysis of the expression of these 15 genes differ-
entiated between both animal groups and resolved the
disease status of the 12 animals.
The 15 genes used for the cluster analysis, expression for
four of which was increased in the infected animals,
included some genes with functions that are not well
described in any species. These include the NRM (nurim
[nuclear envelope membrane protein]), ZDHHC19 (zinc
finger, DHHC-type containing 19), UCP2  (uncoupling
protein 2 [mitochondrial, proton carrier]) and GAN
(giant axonal neuropathy [gigaxonin]) genes. However,
the panel also included well characterized genes of immu-
nological relevance such as the FGFR1 (fibroblast growth
factor receptor 1) gene, the transcription factor NFKB1
gene and the TBK1 gene, a mediator of the action of NF-
κB.
Estimates of the experimental FDR using the SAM package
and permutation analyses showed that the probability of
getting at least 17 genes significant by chance at the P ≤
0.001 level, if there are no real differences between the
classes, was 0.013 (data not shown). Furthermore, 13 of
these 15 genes were represented by two or more signifi-
cant gene features in the original BOTL-5 data. The real
time qRT-PCR verification performed for the NFKB1 and
the TBK1  genes, both of which are represented in the
infection signature panel, supports the reliability of this
method for the detection of a gene infection signature for
BTB (see Table 2 and Fig. 3).
The accuracy of the 15 genes, estimated to be predictive of
disease status in peripheral blood was further analyzed
using leave-one-out cross-validation (LOOCV) [27] as
implemented in BRB ArrayTools version 3.0. LOOCV
analysis confirmed these gene predictors using a number
of analyses including the diagonal linear discriminant,
which classified the gene infection signature with a sensi-
tivity and specificity of 0.833 between BTB-infected and
control animal groups (data not shown). From the 15
gene list, 100% correct classification rate was obtained for
the expression levels of four genes: NCOR1, ZDHHC19,
GAN and an unknown gene represented by clone identi-
fier BOTL0100013_F01 (Table 2).
Discussion
The inability of infected cattle to eliminate M. bovis sug-
gests that the host immune response is inadequate to con-
trol infection in these animals. The specific immune cell
signalling pathways that are involved in the immune
response to intracellular infectious agents are highly com-
plex and poorly characterized in cattle. Although cell-
mediated immunity is known to be critical for the control
of mycobacterial infections; the role of the innate
immune system has only recently been addressed in
human and murine studies [11,8,9]. Cells and molecules
of the innate immune system play a fundamental role in
the detection of pathogen-associated molecular patterns,
in phagocytosis, pathogen destruction, antigen presenta-
tion to T-lymphocytes that drive the production of proin-
flammatory cytokines, and the subsequent activation of
an effective adaptive immune response. Interference in, or
suppression of these molecular mechanisms, due to a
change in the balance of cytokines, or in the pathogen-
induced suppression of cell regulatory pathways may be a
decisive factor in determining the progression of M. bovis
infection in cattle [5,7,28].
The BTB-infected animals used in this study displayed a
significant 29% increase in the relative proportion of lym-
phocytes in their blood (P < 0.001, Fig. 1), accompanied
by a small decrease in the proportion of monocytes (4%).
The production of IFN-γ after in vitro antigenic stimula-
tion indicated the presence of M. bovis-specific T-lym-
phocytes in the BTB-infected lymphocyte populations.
However, despite the influx of lymphocytes, the gene
expression data presented here did not reveal a proinflam-
matory immune response in PBMC from these BTB-
infected animals in vivo. In addition, the BOTL-5 microar-
ray results showed that genes detected with decreased
expression outnumbered genes detected with increased
expression by a factor of two, suggesting gene repression
(Fig. 2).
Estimation of the microarray platform-specific false dis-
covery rate (FDR) provided information regarding the
reliability of the 378 differentially expressed spot features
detected using the BOTL-5 microarray platform under the
specific experimental design and conditions. With 1,391
genes spotted on the array approximately 70 and 14 false
positive genes would be expected using standard statisti-
cal tests at the P ≤ 0.05 and P ≤ 0.01 levels respectively.BMC Genomics 2007, 8:400 http://www.biomedcentral.com/1471-2164/8/400
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However, because each gene on the BOTL-5 microarray is
represented twice, individual spot features are not strictly
independent observations. Furthermore, the array is a tar-
geted immunospecific platform, and as such, represents a
subset of bovine genes that are known to participate in the
immune response and ancillary processes. Therefore,
there is likely to be a relatively high degree of functional
overlap and co-regulation, such that many of these genes
are not strictly independent of one another. Previous work
has shown that the experimental FDR for a porcine brain
microarray platform followed statistical expectations
without the addition of a fold cut-off and that additional
selection criteria could be used to virtually eliminate false
positives [29]. Taken together, the analyses of the FDR in
this study suggest that the microarray data is reliable and
that the FDR was lower than random expectations with
the experimental conditions described.
Ninety of the 122 genes represented by significant repli-
cate spot features were expressed at lower levels in BTB-
infected animals (Fig. 2). Furthermore, the 25 genes
examined by real time qRT-PCR confirmed the BOTL-5
microarray results and supported an overall trend of
repression of the immune response, which may be mani-
fested primarily through decreased expression of innate
immune genes (Fig. 3). Reduced expression of key indica-
tor genes, with well established roles in the bovine
immune response to BTB, associated with BTB-infection
was particularly suggestive of innate immune gene repres-
sion in vivo. The expression of Toll-like receptor genes,
TLR2  and  TLR4  was reduced by 2.4-fold and 1.2-fold
respectively in PBMC from the BTB-infected animals ex
vivo (see Table 1 and Fig. 3). These results suggest that TLR
expression associated with pathogen recognition and
reaction to mycobacteria [12] was suppressed in PMBC of
animals with advanced BTB infection. Significantly, the
Table 2: List of 15 genes significantly differentially expressed at the P < 0.001 level between BTB-infected cattle (n = 6) and control 
cattle (n = 6) from the BOTL-5 microarray data
Array feature/Clone ID Gene symbol Gene name Gene ontology (GO) 
function/s
Infected vs control ani-
mal relative expression
NBFGC_AW656075 NCOR1 Nuclear receptor co-repressor 1 DNA binding, protein binding, 
transcription corepressor activity
-2.12
NBFGC_BF604459 PPP2R5B PP2A protein phosphatase 2A 
B56-beta
Protein phosphatase type 2A 
regulator activity
1.43
BOTL0100001XG10R UCP2 Uncoupling protein 2 (UCP2) 
(mitochondrial, proton carrier)
Binding, transporter activity -1.80
BOTL0100002XD04R UNC84B Unc-84 homolog B Microtubule binding -1.58
BOTL0100003XB12R ZDHHC19 Zinc finger, DHHC-type 
containing 19
Acyltransferase activity, metal ion 
binding, transferase activity, zinc 
ion binding
1.94
BOTL0100003XF01R NFKB1 Nuclear factor of kappa light 
polypeptide gene enhancer in B-
cells 1
Protein binding, transcription 
factor activity
-2.28
BOTL0100004XD01R GAN Giant axonal neuropathy 
(gigaxonin)
Protein binding -1.41
BOTL0100005XF07R SFPQ Splicing factor proline/glutamine 
rich (polypyrimidine tract binding 
protein associated)
DNA, RNA, nucleotide and 
protein binding
-1.67
BOTL0100007_C06 NRM Nurim Nuclear envelope membrane 
protein
-3.07
BOTL0100013_F01 - Unknown Unknown – limited similarity to 
Formin 2
-1.59
Fibroblast growth factor 
receptor 1
FGFR1 Fibroblast growth factor receptor 
1
ATP, nucleotide and protein 
binding. Receptor and tranferase 
activity.
-2.77
NBFGC_BE479784 TBK1 TANK-binding kinase 1 ATP and nucleotide binding. 
Protein kinase and signal 
transducer activity.
-1.63
NBFGC_BE682784 28S 28S ribosomal RNA gene Protein biosynthesis 1.52
NBFGC_BF076990 GPR98 G protein-coupled receptor 98 G-protein coupled receptor 
activity, calcium ion binding
2.07
Neuropilin 1 (NRP1) NRP1 Neuropilin 1 Receptor activity, vascular 
endothelial growth factor 
receptor activity
-2.98
Clone IDs were obtained from the Center for Animal Functional Genomics (CAFG) website [51].BMC Genomics 2007, 8:400 http://www.biomedcentral.com/1471-2164/8/400
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NFKB1 gene, a central mediator of the proinflammatory
immune response and a gene that encodes a mediator of
NF-κB action (TBK1) were both expressed at significantly
reduced levels in BTB-infected animals with P values of
0.023 and 0.004, respectively (see Table 1 and Fig. 3). In
addition, the microarray data indicated reduced expres-
sion of CHUK, a gene that also regulates NF-κB activation,
(P = 0.005), further supporting the trend of immune gene
repression in the BTB-infected animals. NF-κB is a key
transcription factor for many of the genes involved in the
immune response [30], and as such may be a key media-
tor of the gene repression detected in PBMC from the BTB-
infected group.
The CCL1 gene, which encodes a cytokine that displays
chemotactic activity for monocytes [31] also exhibited
reduced expression (Fig. 3). Two genes that encode mem-
bers of the G protein-coupled receptor family involved in
chemotactic T-cell migration, dendritic cell maturation
and recruitment of inflammatory cells (CCR7  and
CXCR3) [32] are also expressed at significantly lower lev-
els in BTB-infected animals based on the microarray data.
Expression of the IL8 gene, which encodes a neutrophil
recruiting chemokine – a key mediator of the inflamma-
tory response – was also reduced (Fig. 3). This observation
was consistent with the reduced NFKB1 gene expression
in the infected animals; NF-κB is a well characterised
mediator of IL8 expression [33]. Furthermore, despite the
relative expansion of lymphocytes in the PBMC from BTB-
infected cattle (Fig. 1), a majority of genes are expressed at
lower levels with no change in the expression of the proin-
flammatory IFNG, IL2  or IL4  genes detected using the
BOTL-5 microarray or real time qRT-PCR (P  = 0.487,
0.772 and P = 0.385 respectively for qRT-PCR results).
Recent studies of human tuberculosis infection demon-
strate that mycobacteria can target cell-signalling path-
ways to regulate gene expression and subvert the host
immune response [reviewed in reference [13]]. One par-
ticular study showed that mycobacteria specifically target
the CD209 (DC-SIGN) molecule causing impaired den-
dritic cell maturation and induction of anti-inflammatory
cytokines that promote immunosuppression [34]. In
addition, other work has suggested that immune cell sig-
nalling suppression may be mediated through TLR-2 [15].
Both of these mechanisms could contribute to the survival
of the mycobacteria.
Previous work using mycobacterial infections has demon-
strated differential expression of TLR-2, TLR-4 [9,35],
inflammatory cytokines including IFN-γ [36,37] and IL-8
[38-41], and BOLA MHC molecules [42,43]. In the
present study, there was no discernible difference in
expression for proinflammatory molecules between the
BTB-infected and control animal groups. This observation
suggests that PBMC from BTB-infected cattle display dif-
ferent gene expression program compared to both the
healthy control animals and to PBMC exposed to M. bovis
antigens in vitro [25].
The differences in cell subpopulations shown between the
BTB-infected and control animal group (Fig. 1) may con-
tribute to some of the gene expression changes detected;
however, the data presented here also supports the
hypothesis that a host- or pathogen-driven process of
innate immune gene repression in BTB-infection in vivo is
responsible for the progression of the disease. These
results are consistent with recent work involving Johne's
disease in cattle caused by M. avium subsp. paratuberculosis
(MAP), where suppression of the immune response was
detected in late stage infection animals [44] and a novel
gene expression program was identified for PBMC in vivo
[22].
One of the aims of this study was to extract gene expres-
sion patterns that are associated with host-pathogen inter-
actions, and that can be interrogated to identify a robust
pathogen-specific molecular signature of infection
[20,45]. It is clear that this approach could be problematic
A gene expression signature of BTB infection Figure 4
A gene expression signature of BTB infection. Hierar-
chical cluster dendrogram constructed with pairwise Pearson 
correlations from BOTL-5 microarray expression data. Data 
from 15 genes differentially expressed at the P ≤ 0.001 level 
were used to construct the dendrogram (scale is expressed 
as units of the Pearson correlation).BMC Genomics 2007, 8:400 http://www.biomedcentral.com/1471-2164/8/400
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because natural gene expression variation for individual
animals and their response to M. bovis infection has not
been characterized [6,28]. However, gene expression
infection signatures do hold promise; a recent study
showed that human gene expression differences due to
disease state were significantly greater than variation due
to natural factors such as age and gender [46]. In addition,
Coussens and co-workers have established two genes
(TNFSF8  and  SELP) in a gene infection signature for
Johne's disease in cattle [23].
The results presented here suggest that gene expression
differences for key immune genes identified using the
BOTL-5 microarray and verified using real time qRT-PCR
play a role in disease pathogenesis and importantly, that
these genes may serve as biomarkers for BTB-infection sta-
tus. Cluster analysis identified a panel of 15 genes indica-
tive of disease status in PBMC from naturally infected
animals, in the absence of antigenic stimulation with
tuberculin. In addition, results from class prediction anal-
yses allocated a sensitivity and specificity score of 83% for
these gene classifiers as predictive of disease status for the
two groups of animals used. Taking these observations
into consideration, these genes may therefore represent
robust and stable biomarkers for BTB infection. We are
currently investigating the sensitivity and specificity of
this gene infection signature in a larger cohort of naturally
infected and uninfected cattle.
Conclusion
The results from the present study support a primary trend
of innate immune gene repression in PBMC from BTB-
infected animals. Additionally, a distinct gene expression
profile that is predictive of disease state is evident, that
also sheds light on the cell regulatory pathways associated
with pathogenesis of bovine tuberculosis. However, it is
important to note that different patterns of gene expres-
sion may be evident in tissues at the sites of active infec-
tion. Also, some of the gene expression changes we
observed may not be specific for M. bovis infection and
may represent a general phenomenon associated with
other advanced stage infections or pathologies.
This study highlights the importance of the natural host
for  M. bovis infection as a model to investigate the
immune response to tuberculosis using functional
genomics technologies. Genes and cellular regulatory
pathways involved in the bovine innate immune response
to tuberculosis will likely show evolutionary overlap with
mechanisms of response to M. tuberculosis in humans.
These results also suggest that clinical strategies that target
novel innate immune molecules might be useful in com-
bating mycobacterial infections by shifting the balance
between immune activation and suppression to favour
the elimination of pathogens.
Methods
Experimental animals
Sixteen cattle were used for this study. The eight infected
animals were chosen from herds with a recent history of
chronic infection with M. bovis. The animals were selected
on the basis of the skin-fold thickness response to bovine
and avian tuberculin in the single intradermal compara-
tive tuberculin test (SICTT). The SICTT reactor animals
were selected where the skin-fold thickness response to
PPD-bovine exceeded that of PPD-avian by at least 12
mm. All of these animals were also measured positive in a
whole blood IFN-γ assay [47]. The cattle were confirmed
positive for tuberculosis following detailed post-mortem
pathological examination and/or culture. Bronchial,
mediastinal, submandibular, retropharyngeal, mesenteric
and hepatic lymph nodes and lungs were examined mac-
roscopically for tuberculosis lesions. Suspected lesions
were cultured on Stonebrinks and Lowenstein-Jensen
media at 37°C for eight weeks to detect M. bovis [48]. The
eight non-infected control animals were selected from a
herd without a recent history of tuberculosis and were
SICTT and IFN-γ test negative.
Blood sampling and analysis
400 ml of blood was collected from each animal in sterile
heparinised bottles. Five ml of blood was used for haema-
tological analysis using an Abbott CELL-DYN 3500R auto-
mated haematology analyzer (Abbott Laboratories).
Leukocyte cell population subsets were compared
between infected and control groups (n = 8) using Stu-
dent's t-test.
PBMC separation, RNA extraction and quality control
PBMC were isolated using the Percoll™ gradient method
with a standard protocol [49]. PBMC were seeded at 107
per culture plate and cultured in RPMI 1640 medium sup-
plemented with 5% FBS, 0.1% mercaptoethanol and
0.1% gentamicin. All PBMC samples were cultured over-
night at 37°C in 5% CO2. Overnight culture was carried
out to minimise noise in gene expression measurements
potentially introduced by the mechanical disruption of
cells associated with PBMC isolation. Residual cells not
seeded for culture were immediately suspended in 3 ml
TriReagent® (Molecular Research Centre Inc.) and frozen
in 1.5 ml cryotubes at -80°C for use later as a common ref-
erence RNA (CRR) pool. Total RNA was extracted using a
combined TriReagent®, DNase treatment and Qiagen
RNeasy® method (Qiagen Ltd.) according to the manufac-
turers' instructions. The integrity and stability of RNA
samples is crucial for gene expression analyses using
microarray technology; therefore, RNA yield and quality
were assessed using an Agilent 2100 Bioanalyzer (Agilent
Technologies). The two-step method for RNA extraction
described above was found to produce RNA of high yieldBMC Genomics 2007, 8:400 http://www.biomedcentral.com/1471-2164/8/400
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and quality (ratios of 18S to 28S ribosomal RNA averaged
> 1.6).
Microarray experimental design
The 3,888 feature BOTL-5 immunogenetic cDNA microar-
ray system used has been described previously [50]. Tech-
nical information with gene content and sequence
information for the BOTL-5 array can be downloaded
from the 'Links' section on the MSU Center for Animal
Functional Genomics website [51]. The NCBI GEO plat-
form accession for the BOTL-5 microarray is: GPL5751.
The immunobiology-targeted BOTL-5 array contains
1,391 genes or ESTs spotted in duplicate with multiple
additional control features (blank spots, negative spots,
housekeeping genes) and is an expanded version of the
BOTL-4 array described previously [52,25]. A reference
design was used for microarray hybridizations, such that
all RNA samples were labelled using Cy3 and co-hybrid-
ized with Cy5 labelled CRR pool. It was hypothesized that
the CRR pool would display similar mRNA expression lev-
els and gene coverage as the target samples, therefore
allowing accurate and consistent comparison of gene
expression data without arbitrarily pairing animals from
the two groups [53]. The CRR pool contained equal
amounts of total RNA from the treated and control animal
groups. Twelve arrays were hybridized in total, represent-
ing six individual animals from each treatment group.
cDNA labelling, hybridisation and scanning
cDNA synthesis, Cy3 and Cy5 labelling and microarray
hybridizations were performed as previously described
[25] with the following modifications. Each labelling
reaction contained a total of 8 µg total RNA per sample
and 10 µg total RNA from the CRR. Labelled cDNAs were
purified to remove unincorporated dyes using a
QIAquick® purification kit (Qiagen Ltd.) and concentrated
using Microcon® centrifugal filter devices (Millipore Ltd.)
according to the manufacturers' instructions. Labelled
samples were combined (either an infected or a control
sample combined with a CRR sample) and co-hybridized
on the BOTL-5 microarrays using SlideHyb Glass Array
Hybridization Buffer #3 (Ambion Ltd.). Microarray
hybridizations were performed using a Tecan HS400
hybridisation station (Tecan Ltd.) with the following pro-
tocol – Step 1: 75°C, wash 10 s, soak 20 s, 1 cycle; probe
injection: 85°C; denaturation: 95°C, 2 min; hybridiza-
tion cycle 1: 65°C, time 35 min, agitation frequency
medium; hybridization cycle 2: 55°C, time 35 min, agita-
tion frequency medium; hybridization cycle 3: 50°C, time
2 h 30 m, agitation frequency medium; wash cycle 1:
42°C, wash 10 s, soak 20 s, 2 cycles; wash cycle 2: 33°C,
wash 15 s, soak 30 s, 2 cycles; wash cycle 3: 33°C, wash 20
s, soak 40 s, 2 cycles; slide drying: 30°C, 1 min 30 s.
Microarrays were scanned immediately using a GenePix
4000B microarray scanner (Molecular Devices Ltd.). Data
was captured using GenePix Pro version 5.0 software
(Molecular Devices Ltd.).
Data processing, normalization and analysis and clustering
The working signal intensities were generated using the
mean foreground intensity values minus the median
background intensity values as outputted from the Gene-
Pix Pro 5.0 results file. Two methods of data pre-process-
ing were used to flag unreliable data. If the signal intensity
in one channel was less than 100 and if the signal inten-
sity for the other channel is less than 200, the spot was
flagged. If the signal intensity in one channel was less than
100 and the signal intensity was larger than 200 in the sec-
ond channel, 100 was assigned to the intensity of the first
channel.
Median-based normalization corrects the data such that
all arrays have the same median [54]. The median value is
less likely to be influenced by outlying values. A normali-
zation factor was calculated by summing the intensities in
both channels and adjusts both ratios to ensure a median
of 1.0. Therefore, the median log expression ratio for all
features on the array was adjusted to zero (corresponding
to an expression ratio of 1.0). The formula used for
median normalization is as follows:
Where Cjk represents the normalisation factor, S the set of
genes for normalization, Rjkthe observed log ratio of the
red (Cy5) channel and Gjkthe observed log ratio of the
green (Cy3) channel [55,56].
Microarray data analysis was carried out using class com-
parisons between experimental groups (parametric t-tests)
as implemented in BRB ArrayTools version 3.0 [57].
Microarray platform-specific false discovery rate
The false discovery rate (FDR) for the microarray data was
investigated using permutation analysis. Data sets for
individual samples were randomly assigned control or
infected status to produce new permuted data. This proce-
dure was carried out for 1,000 permutations and the
number of differentially expressed genes for each per-
muted data set was then estimated using BRB ArrayTools.
In addition, the experiment-specific FDR was further
examined using the Significance Analysis of Microarrays
(SAM) version 2.0 package [58].
Supervised cluster analysis
Gene expression profiles for each animal were clustered
using average linkage hierarchical clustering implemented
in the BRB ArrayTools version 3.0 package with pairwise
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Table 3: Real time qRT-PCR primer sequences, optimum primer concentrations and amplicon sizes for all validated genes.
Array feature/Clone ID Gene symbol Forward primer (5'-3') Reverse primer (5'-3') Amplicon size (bp) Primer conc. (nM)
Reference gene H3F3A CATGGCTCGTACAAAGCAGA ACCAGGCCTGTAACGATGAG 136 100
PCR Amplicon ACTB AAGCCGGCCTTGCACAT TAACTCGAGAGCCAACGTCTCC 66 900
NBFGC_BE752490 ADAM17 TCAAAGTCGTGGTGGTAGATGG AATTAGTCTCCAAAGCGGCTCT 188 900
NBFGC_AW656779 AKT1 GAGTACTTCAGGGCCGTCAG GGTGATCCTGGTGAAGGAGA 160 900
PCR Amplicon BCL2 ATGACTTCTCTCGGCGCTAC ATGACCGAGTACCTGAACCG 244 300
PCR Amplicon CCL1 AGGCTGGATCTGCTCCCAAAT GGTGATGTGTGCAAGTTCACCA 152 900
BOTL0100003XA07R CD81 TTCATGTCCTGAAGCTCCCTGT TGAAGGCATAAGGCTGCTCGT 284 300
BOTL0100013_C12 CD84 TAAGTGGTGTGTCATGGCAGGT GGCTGGAGGCTGAATATGACTG 103 300
PCR Amplicon CXCR3 GAAAGCAGTGTGGACATAGCCA CGGAACTTGACACCCACAAAG 101 900
NBFGC_BF230159 EEF1G TGGATGCTCACTTGAAGACG ACTGGGCCATTTTCTCACAG 222 300
PCR Amplicon GAPDH CTCCCAACGTGTCTGTTGTG TGAGCTTGACAAAGTGGTCG 222 300
BOTL0100013_E07 IER5 AAGACCCCCGAGACTTCG ACACTCTTCAAGGCGGAGAG 115 300
PCR Amplicon IFNG TGATGGCATGTCAGACAGCA GGCACAAGTCATATAGCCTGACAC 51 300
PCR Amplicon IL2 CTTGCACTCGTTGCAAACG CAAGCTCTCCAGGATGCATACA 183 300
PCR Amplicon IL4 GCCACACGTGCTTGAACAAA TCTCAACAGCTTGGCAAGCA 63 300
PCR amplicon IL8 AGGTGGTGTTTGAAGCCCAT CACAACCTTCTGCACCCACTT 123 900
PCR Amplicon IL16 CGCGGTTTGAAGAATGGAAC TCACAGGTCCATCAGGCAAC 51 300
PCR Amplicon MCL1 AGGTGACTGAAAGGCCTGTCTC CAACATGTGCCTCTTCTCCCT 244 900
BF775342 NFATC4 NFATC4 AACCACTGCCCCTCTCTGAAAC CCTCGACCCCAGATCACAAAGA 107 300
BOTL0100003XF01R NFKB1 ATACTGAACAATGCCTTCCGG CACGTCAATGGCCTCAGTGTAG 135 300
BOTL0100013_G05 PHB2 GGCGGCGCGGATGT AGGTTATATCAAGCTACGCAAGATCC 65 900
NBFGC_AW335987 PRKCB1 ATCGAGAGGGAGGTCCTCAT GGTCTTGGTCTTCTGCTTGC 141 300
PCR Amplicon RPL19 AATGCCCGAGAAGGTAACCTG GGATATGTTCCATGAGGATCCG 164 100
NBFGC_AW669767 RPS6KB2 TGTGGAACTGGCCTATGCCTTC AAGATGCCTTCTCGCTCCAGGT 105 300
PCR Amplicon STK17B ACAGGCCCTCTTGTAATGGCAC AGCAAATCGGACACAAGCTCG 136 300
NBFGC_BE479784 TBK1 TGGACCAATTGACTGGAGTGGA TGATCTGCCTCAAGGATGTTTG 105 300
Not represented TLR2 CCATTGACAAGAAGGCCAT AACCCTTCCTGCTGAGTCTCAT 107 900
Not represented TLR4 CGAGAGCACCTATGATGCCTTT ATGGCCACCCCAGGAATAAA 144 900
PCR Amplicon TNF TCTACCAGGGAGGAGTCTTCCA GTCCGGCAGGTTGATCTCA 68 300
Clone IDs were obtained from the Center for Animal Functional Genomics (CAFG) website [51].BMC Genomics 2007, 8:400 http://www.biomedcentral.com/1471-2164/8/400
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Pearson correlations as the distance metric. To test the
accuracy of the clustered class predictors whose expression
state changed between classes at the P ≤ 0.001 level, a
method of class prediction was used as implemented in
BRB ArrayTools. Leave-one-out cross-validation (LOOCV)
was performed to test the accuracy of each class predictor
and compared to the probability of a correct class predic-
tion by chance alone, based on the P-value and total
number of genes analyzed [27].
Real time quantitative reverse transcription PCR
Replicate spot features on the BOTL array were used as a
check for the quality control of gene expression data. Each
spot was analyzed individually thereby allowing the indi-
vidual genes to be flagged if expression results from two or
more replicates were statistically different. This enabled
the identification of differentially expressed genes that
had a low probability of being false positives and expe-
dited the choice of target genes for real time qRT-PCR val-
idation of the microarray results. The H3 histone family
3A (H3F3A) gene was used as a quantitative reverse tran-
scription PCR (qRT-PCR) reference gene for the present
study. This gene displayed the least gene expression differ-
ences among the 12 control and BTB-infected samples
analyzed using the BOTL microarray platform (data not
shown).
Gene expression differences detected using the BOTL
microarray platform were validated using a MX3000P™
fluorescence detection real-time PCR system (Stratagene
Europe). Total RNA samples from each of the 16 samples
(representing 8 animals per treatment group) were con-
verted into first strand cDNAs with the following proto-
col: 2 µg of each RNA was combined with 10 mM oligo
(dT)12–18 primer and DNase/RNase-free sterile water in a
10-µl volume that was incubated for 5 min at 70°C fol-
lowed by 5 min at 20°C. A mastermix containing 200 U
M-MuLV reverse transcriptase (New England Biolabs
Ltd.), 2 µl of reaction buffer (final reagent concentrations
of 50 mM Tris-HCl, pH 8.3, 75 mM KCl, 3 mM MgCl2 and
10 mM DTT), and a final concentration of 0.5 mM each
dNTP were added to obtain a final reaction volume of 20
µl. Reverse transcription was allowed to proceed at 42°C
for 60 min and then samples were heated to 72°C for 15
min, cooled to 37°C prior to the addition of 2 U of
DNase-free RNAase H (Invitrogen Ltd.). Incubation at
37°C was continued for 20 min with RNase H to remove
the original RNA template followed by enzyme inactiva-
tion with 0.5 µl of 0.5 M EDTA (pH 8.0). First-strand
cDNAs were purified with QuickClean resin according to
the manufacturer's instructions (BD Biosciences) fol-
lowed by precipitation in 80% ethanol supplemented
with 100 mM sodium acetate. Purified cDNAs were sus-
pended in DNase/RNase-free sterile water, quantified
using an Agilent Bioanalyzer (Agilent Technologies) and
diluted to a final concentration of 10 ng/µl and stored at -
80°C until required. Gene-specific oligonucleotide
primer pairs were designed using Primer Express® version
2.0 software (Applied Biosystems) and synthesized com-
mercially (Invitrogen Ltd.). Experimental details for these
primer pairs are shown in Table 3. Real-time qRT-PCR
reactions were performed in 25 µl reaction volumes with
0.5 µl HOT FIREPol ® DNA polymerase and buffer (Solis
Biodyne Inc.), 2.5 µl of 10 × manufacturer's reaction
buffer B, 2.5 µl of 25 mM MgCl2 and 2.5 µl of 2 mM dNTP
mix, optimized primer mix and water made to 14.1 µl
(final concentrations ranging from 100 – 900 nM each,
Table 3), 1.25 µl of a 1/60,000 dilution of SYBR ® Green I
dye (BioGene Ltd.) and 2 µl (20 ng) of cDNA template.
Real-time qRT-PCR amplification conditions were always
95°C for 1 min followed by 40 cycles of 95°C for 15 s
then 60°C for 60 s. All reactions were performed in dupli-
cate and amplicons for the H3F3A reference gene mRNA
transcript were used to normalize expression data for the
target genes.
Real time qRT-PCR data were analysed using the 2-∆∆Ct
method [59] as described previously [25]. Real time qRT-
PCR gene expression log2 values from both groups were
compared using Student's t-test.
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